Fucoidan as a Marine Anticancer Agent in Preclinical Development
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Fucoidan is a fucose-containing sulfated polysaccharide derived from brown seaweeds, crude extracts of which are commercially available as nutritional supplements. Recent studies have demonstrated antiproliferative, antiangiogenic, and anticancer properties of fucoidan in vitro. Accordingly, the anticancer effects of fucoidan have been shown to vary depending on its structure, while it can target multiple receptors or signaling molecules in various cell types, including tumor cells and immune cells. Low toxicity and the in vitro effects of fucoidan mentioned above make it a suitable agent for cancer prevention or treatment. However, preclinical development of natural marine products requires in vivo examination of purified compounds in animal tumor models. This review discusses the effects of systemic and local administration of fucoidan on tumor growth, angiogenesis, and immune reaction and whether in vivo and in vitro results are likely applicable to the development of fucoidan as a marine anticancer drug.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berteau, O. (2003) · Glycobiology · doi:10.1093/glycob/cwg058 · Cited by 769
Structure, biology, evolution, and medical importance of sulfated fucans and galactans
Pomin, V. H., & Mourao, P. A. S. (2008) · Glycobiology · doi:10.1093/glycob/cwn085 · Cited by 356
Brown seaweed fucoidan: Biological activity and apoptosis, growth signaling mechanism in cancer
Senthilkumar, K., Manivasagan, P., Venkatesan, J., & Kim, S.-K. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.06.030 · Cited by 340
Ale, M. T., Maruyama, H., Tamauchi, H., Mikkelsen, J. D., & Meyer, A. S. (2011) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2011.05.009 · Cited by 267
Yang, C., Chung, D., Shin, I.-S., Lee, H., Kim, J., Lee, Y., & You, S. (2008) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2008.08.006 · Cited by 254
Alekseyenko, T. V., Zhanayeva, S. Y., Venediktova, A. A., Zvyagintseva, T. N., Kuznetsova, T. A., Besednova, N. N., & Korolenko, T. A. (2007) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-007-0226-4 · Cited by 244
Structure, biological activity, and enzymatic transformation of fucoidans from the brown seaweeds
Kusaykin, M., Bakunina, I., Sova, V., Ermakova, S., Kuznetsova, T., Besednova, N., Zaporozhets, T., & Zvyagintseva, T. (2008) · Biotechnology Journal · doi:10.1002/biot.200700054 · Cited by 197
Anticancer properties and mechanisms of fucoidan on mouse breast cancer in vitro and in vivo
Xue, M., Ge, Y., Zhang, J., Wang, Q., Hou, L., Liu, Y., Sun, L., & Li, Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043483 · Cited by 192
Zhang, Z., Teruya, K., Eto, H., & Shirahata, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027441 · Cited by 167
Maruyama, H., Tamauchi, H., Iizuka, M., & Nakano, T. (2006) · Planta Medica · doi:10.1055/s-2006-951703 · Cited by 151
Cited by
Sulfated Seaweed Polysaccharides as Multifunctional Materials in Drug Delivery Applications
Cunha, L., & Grenha, A. (2016) · Marine Drugs · doi:10.3390/md14030042 · Cited by 611
Seaweeds as a Functional Ingredient for a Healthy Diet
Peñalver, R., Lorenzo, J. M., Ros, G., Amarowicz, R., Pateiro, M., & Nieto, G. (2020) · Marine Drugs · doi:10.3390/md18060301 · Cited by 488
Therapies from Fucoidan: An Update
Fitton, J., Stringer, D., & Karpiniec, S. (2015) · Marine Drugs · doi:10.3390/md13095920 · Cited by 418
Fucoidan and Cancer: A Multifunctional Molecule with Anti-Tumor Potential
Atashrazm, F., Lowenthal, R., Woods, G., Holloway, A., & Dickinson, J. (2015) · Marine Drugs · doi:10.3390/md13042327 · Cited by 358
Karthikeyan, A., Joseph, A., & Nair, B. G. (2022) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-021-00290-4 · Cited by 336
Deniaud-Bouët, E., Hardouin, K., Potin, P., Kloareg, B., & Hervé, C. (2017) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2017.07.082 · Cited by 326
Salehi, B., Sharifi-Rad, J., Seca, A. M. L., Pinto, D. C. G. A., Michalak, I., Trincone, A., Mishra, A. P., Nigam, M., Zam, W., & Martins, N. (2019) · Molecules · doi:10.3390/molecules24224182 · Cited by 314
Chiang, C.-S., Lin, Y.-J., Lee, R., Lai, Y.-H., Cheng, H.-W., Hsieh, C.-H., Shyu, W.-C., & Chen, S.-Y. (2018) · Nature Nanotechnology · doi:10.1038/s41565-018-0146-7 · Cited by 283
Potential biomedical applications of marine algae
Wang, H.-M. D., Li, X.-C., Lee, D.-J., & Chang, J.-S. (2017) · Bioresource Technology · doi:10.1016/j.biortech.2017.05.198 · Cited by 217
Jin, J.-O., Zhang, W., Du, J.-Y., Wong, K.-W., Oda, T., & Yu, Q. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099396 · Cited by 160
Dang, T. T., Van Vuong, Q., Schreider, M. J., Bowyer, M. C., Van Altena, I. A., & Scarlett, C. J. (2017) · Journal of Applied Phycology · doi:10.1007/s10811-017-1162-y · Cited by 116
“…(Miyake et al. 2006), preventing cardiovascular diseases (Shi et al. 2010), neuroprotective effects (Alghazwi et al. 2016), anti-diabetes (Okada et al. 2004), and against several types of cancers (Cabrita et al. 2010; De Souza et al. 2009; Ferreres et al. 2012; Kumar et al. 2013; Kwak 2014).”
BackgroundTocaciu, S., Oliver, L. J., Lowenthal, R. M., Peterson, G. M., Patel, R., Shastri, M., McGuinness, G., Olesen, I., & Fitton, J. H. (2018) · Integrative Cancer Therapies · doi:10.1177/1534735416684014 · Cited by 71
Activation of NK cells in male cancer survivors by fucoidan extracted from Cladosiphon okamuranus
Nagamine, T., Kadena, K., Tomori, M., Nakajima, K., & Iha, M. (2019) · Molecular and Clinical Oncology · doi:10.3892/mco.2019.1943 · Cited by 27
Metadata
- Authors
- Kwak, J.-Y.
- Venue
- Marine Drugs
- Publisher
- MDPI AG
- Published
- 2014-01-28
- Volume
- 12
- Issue
- 2
- Pages
- 851-870
- ISSN
- 1660-3397 (ISSN-L)
- OpenAlex
- W1979518180
- Cited by
- 220
- References
- 19
- FWCI
- 34.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.